PAVmed (FRA:1P5) E10: € (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:1P5 PAVmed Inc FRA:1P5
44 GF Score
Price €3.32
GF Value €1.01
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is PAVmed E10?

PAVmed FRA:1P5 +1.52% 44 E10 is € as of Jun. 2026. GuruFocus rates FRA:1P5 with a GF Score™ of 44/100 and a GF Value™ of €1.01 (Significantly Overvalued). The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

PAVmed's adjusted earnings per share data for the three months ended in Jun. 2026 was €-0.752. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is for the trailing ten years ended in Jun. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2026-09-22), PAVmed's current stock price is €3.32. PAVmed's E10 for the quarter that ended in Jun. 2026 was . PAVmed's Shiller PE Ratio of today is .


PAVmed  (FRA:1P5) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


PAVmed E10 Related Terms


PAVmed E10 Historical Data

* Premium members only.

The historical data trend for PAVmed's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PAVmed E10 Chart

PAVmed Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

PAVmed Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

FRA:1P5 vs ELUT, NSPR, SNWV: E10 Comparison

For the Medical Devices subindustry, PAVmed's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PAVmed Shiller PE Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, PAVmed's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where PAVmed's Shiller PE Ratio falls into.


FRA:1P5
44GF Score
PAVmed Inc FRA:1P5
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PAVmed E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, PAVmed's adjusted earnings per share data for the three months ended in Jun. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=-0.7516/333.9520*333.9520
=-0.752

Current CPI (Jun. 2026) = 333.9520.

PAVmed Quarterly Data

per share eps CPI Adj_EPS
201609 -56.450 241.428 -78.084
201612 -54.251 241.432 -75.040
201703 -135.108 243.801 -185.067
201706 -31.933 244.955 -43.534
201709 -153.364 246.819 -207.505
201712 8.133 246.524 11.017
201803 -75.573 249.554 -101.132
201806 -100.425 251.989 -133.089
201809 -48.272 252.439 -63.860
201812 -100.193 251.233 -133.182
201903 -52.555 254.202 -69.043
201906 -53.104 256.143 -69.236
201909 -41.125 256.759 -53.489
201912 -77.238 256.974 -100.375
202003 -136.580 258.115 -176.709
202006 -51.549 257.797 -66.777
202009 -44.249 260.280 -56.774
202012 -64.390 260.474 -82.554
202103 -48.023 264.877 -60.547
202106 -52.443 271.696 -64.460
202109 -56.333 274.310 -68.581
202112 -78.790 278.802 -94.376
202203 -78.706 287.504 -91.421
202206 -124.286 296.311 -140.074
202209 -130.388 296.808 -146.705
202212 -95.901 296.797 -107.907
202303 -77.775 301.836 -86.050
202306 -57.898 305.109 -63.371
202309 -65.583 307.789 -71.158
202312 -54.013 306.746 -58.804
202403 -72.442 312.332 -77.457
202406 -33.209 314.175 -35.300
202409 39.344 315.301 41.671
202412 3.380 315.605 3.577
202503 9.608 319.799 10.033
202506 -19.477 322.561 -20.165
202509 -7.537 324.800 -7.749
202512 -2.034 324.054 -2.097
202603 -3.779 330.213 -3.821
202606 -0.752 333.952 -0.752

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of € mean?
PAVmed (FRA:1P5) has a E10 of € as of Jun. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on PAVmed and its competitors.
Is PAVmed's E10 too high?
PAVmed's current E10 is €. Overall, PAVmed has a GF Score™ of 44/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does PAVmed's E10 compare to ELUT and NSPR?
PAVmed's E10 of € can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Medical Devices & Instruments company?
A good E10 depends on the Medical Devices & Instruments industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on PAVmed and its competitors. PAVmed's current E10 is €. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PAVmed stock overvalued right now?
Based on GuruFocus' analysis, PAVmed (FRA:1P5) is currently considered Significantly Overvalued. The stock's GF Value™ is €1.01, compared to a current price of €3.32 — trading 228.7% above its estimated fair value. The current E10 is €. PAVmed's overall GF Score™ is 44/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For PAVmed (FRA:1P5), the current E10 is € as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PAVmed (FRA:1P5) Overvalued in 2026?

Based on GuruFocus' analysis, PAVmed stock appears to be overvalued. The current stock price of €3.32 is trading 228.7% above its estimated GF Value™ of €1.01. GuruFocus considers PAVmed to be Significantly Overvalued.

Key valuation signals for FRA:1P5:

  • E10:
  • GF Value™: €1.01 vs. price of €3.32 (228.7% above fair value)
  • GF Score™: 44/100 with 5 warning signs

No single metric tells the full story. See the FRA:1P5 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


PAVmed Business Description

Other Exchanges PAVM:USA
Address 360 Madison Avenue, 25th Floor, New York, NY, USA, 10017
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, EsoCheck, and the Veris Cancer Care Platform.
44GF Score

Get the complete analysis for FRA:1P5

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€3.32
Price
€1.01
GF Value